Staff Members - Benha University
Role of ascorbic acid in reduction of the incidence of the atrial fibrillation in patients under B-blocker and undergoing coronary artery bypass graft operation in early post-operative period
• 2017
Publication Information
Authors
Mohammed K. Alshafey MD a, 1, Hany M. Elrakhawy MD a, 2,
Moataz E. Rezk MD a, *, Hani M. Moustafa MSC b, 3
Keywords
Ascorbic acid
b -blockers
Atrial fibrillation
Journal
Not Available
Publisher
Not Available
Volume
Not Available
Issue
Not Available
Pages
Not Available
publication.type
International
Paper Link
Not Available
Supplementary Materials
Not Available
Abstract
Background: The study was done to project the important role of the anti-inflammatory
and anti eoxidant properties of Ascorbic acid (vitamin C) in reducing the incidence of
atrial fibrillation (AF) in the early post-operative period after coronary artery bypass graft
operation (CABG).
Methods: This prospective randomized study included 100 patients admitted to cardiothoracic
surgery department, Benha University Hospital, Benha, Egypt between 2011 and
2016. Those patients scheduled for CABG, were randomized into two groups of patients:
the first; group 1: A fifty CABG patients were given b -blocker (bisoprolol 5 mg o.d.) &
ascorbic acid (2 g daily in divided doses qds) for at least three days pre-operatively. The
second; group 2: A fifty CABG patients were given b -blocker (bisoprolol 5 mg o.d.) for at
least three days pre-operatively. Patients were followed up for AF after (CABG) for the
short term of 3 weeks.
Results: The incidence of AF after CABG in1st 48 h and after 1 month was statistically
significantly lower in Group 1 than Group 2 with p value 0.022 and 0.025 respectively.
Intensive care unit stay, need for inotropic support and ventilator stay were also significantly
decreased in Group1 than Group 2 with p value 0.035, 0.045 and 0.048 respectively.
Conclusions: The incidence of post CABG AF, intensive care unit stay, need for inotropic
support and ventilator stay were decreased by patients intake of vitamin C in combination
with b -blockers pre-operatively.
© 2017 The Egyptian Society of Cardio-thoracic Surgery. Publishing services by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
and anti eoxidant properties of Ascorbic acid (vitamin C) in reducing the incidence of
atrial fibrillation (AF) in the early post-operative period after coronary artery bypass graft
operation (CABG).
Methods: This prospective randomized study included 100 patients admitted to cardiothoracic
surgery department, Benha University Hospital, Benha, Egypt between 2011 and
2016. Those patients scheduled for CABG, were randomized into two groups of patients:
the first; group 1: A fifty CABG patients were given b -blocker (bisoprolol 5 mg o.d.) &
ascorbic acid (2 g daily in divided doses qds) for at least three days pre-operatively. The
second; group 2: A fifty CABG patients were given b -blocker (bisoprolol 5 mg o.d.) for at
least three days pre-operatively. Patients were followed up for AF after (CABG) for the
short term of 3 weeks.
Results: The incidence of AF after CABG in1st 48 h and after 1 month was statistically
significantly lower in Group 1 than Group 2 with p value 0.022 and 0.025 respectively.
Intensive care unit stay, need for inotropic support and ventilator stay were also significantly
decreased in Group1 than Group 2 with p value 0.035, 0.045 and 0.048 respectively.
Conclusions: The incidence of post CABG AF, intensive care unit stay, need for inotropic
support and ventilator stay were decreased by patients intake of vitamin C in combination
with b -blockers pre-operatively.
© 2017 The Egyptian Society of Cardio-thoracic Surgery. Publishing services by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).